Interim results of a phase I/II clinical trial of a DNA plasmid vaccine (BHT-3021) for type 1 diabetes

被引：0
|
作者：
Gottlieb, P. [1 ]
Eisenbarth, G. [1 ]
Harrison, L. [2 ]
Colman, P.
Roep, B. [3 ]
Quan, J. [4 ]
Solvason, N. [4 ]
Steinman, L. [5 ]
Garren, H. [4 ]
机构：
[1] Barbara Davis Ctr, Aurora, CO USA
[2] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[3] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
[4] Bayhill Therapeut Inc, San Mateo, CA USA
[5] Stanford Univ, Stanford, CA 94305 USA
来源：
DIABETOLOGIA | 2009年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188
引用
收藏
页码：S83 / S83
页数：1
相关论文
共 50 条
  • [1] Interim Results of a Phase I/II Clinical Trial of a DNA Plasmid Vaccine (BHT-3021) for Type 1 Diabetes
    Eisenbarth, George
    Colman, Peter
    Gottlieb, Peter
    Harrison, Leonard
    Quan, Joanne
    Roep, Bart
    Solvason, Nanette
    Steinman, Lawrence
    Garren, Hideki
    CLINICAL IMMUNOLOGY, 2009, 131 : S84 - S84
  • [2] Interim results of a phase I/II clinical trial of a DNA plasmid (BHT-3021) for type 1 diabetes
    Gottlieb, Peter A.
    Eisenbarth, George S.
    Kipnes, Mark
    Ratner, Robert
    Rockell, Jennifer
    Wagner, Rebecca
    Garren, Hideki
    DIABETES, 2008, 57 : A580 - A580
  • [3] Interim results of a phase I/II clinical trial of a DNA plasmid (BHT-3021) for type 1 diabetes
    Gottlieb, P.
    Eisenbarth, G. S.
    Kipnes, M.
    Ratner, R.
    Rockell, J.
    Wagner, R.
    Valone, F.
    Garren, H.
    DIABETOLOGIA, 2008, 51 : S233 - S233
  • [4] Interim Results-of a Phase I/II Clinical Trial of a DNA Plasmid Vaccine (BAT-3021) for Type 1 Diabetes
    Gottlieb, Peter
    Colman, Peter G.
    Kipnes, Mark
    Ratner, Robert
    Aroda, Vanita
    Rendell, Marc
    Gerstman, Murray
    Zemel, Leonard
    Dunn, Peter
    Hays, Richard
    Heazlewood, Vernon
    Baker, John
    Scott, Russell
    Davis, Timothy
    Greenbaum, Carla
    Krebs, Jeremy
    Norwood, Paul
    Ovalle, Fernando
    Raskin, Phillip
    Skyler, Jay S.
    Quan, Joanne
    Solvason, Nanette
    Roep, Bart
    Harrison, Leonard C.
    Eisenbarth, George
    Steinman, Lawrence
    Garren, Hideki
    DIABETES, 2009, 58 : A30 - A31
  • [5] One-Year Results from a Phase 1/2 Clinical Trial of BHT-3021, a DNA Plasmid Vaccine for Type 1 Diabetes (T1D)
    Gottlieb, Peter
    Colman, Peter G.
    Solvason, Nanette
    Otto, Kelly
    Roep, Bart
    Harrison, Leonard C.
    Eisenbarth, George
    Robinson, William
    Utz, Paul J.
    Steinman, Lawrence
    Garren, Hideki
    Quan, Joanne
    DIABETES, 2010, 59 : A18 - A18
  • [6] Positive interim results from Phase I/II multiple myeloma cancer vaccine trial
    Riedmann, Eva M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (06) : 696 - 697
  • [7] DNA vaccine against HCV enters Phase I/II clinical trial
    不详
    EXPERT REVIEW OF VACCINES, 2007, 6 (06) : 890 - 890
  • [8] Cytomegalovirus vaccine: phase II clinical trial results
    Rieder, F.
    Steininger, C.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 95 - 102
  • [9] Phase I/II trial of a MBP encoding DNA plasmid (BHT-3009) alone or combined with atorvastatin for treatment of multiple sclerosis
    Vollmer, T
    Lapierre, Y
    Weiner, L
    Oger, J
    Bar-Or, A
    Arnold, D
    Campagnolo, D
    Barkas, W
    Antel, J
    Kachuck, N
    Garren, H
    Gianettoni, J
    Steinman, L
    Valone, F
    NEUROLOGY, 2006, 66 (05) : A62 - A62
  • [10] A phase 1 clinical trial of a dengue-1 DNA vaccine: Preliminary results
    Beckett, Charmagne
    Tjaden, Jeffrey
    Burgess, Timothy
    Danko, Janine
    Tamminga, Cindy
    Simmons, Monika
    Wu, Shuenn-Jue
    Sun, Peifang
    Kochel, Tadeusz
    Raviprakash, Kanakatte
    Hayes, Curtis
    Porter, Kevin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 34 - 34
12345